Eli Lilly (LLY) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Eli Lilly (LLY) over the last 14 years, with Q3 2025 value amounting to $6.21.
- Eli Lilly's EPS (Weighted Average and Diluted) rose 48037.38% to $6.21 in Q3 2025 from the same period last year, while for Sep 2025 it was $20.44, marking a year-over-year increase of 12097.3%. This contributed to the annual value of $11.71 for FY2024, which is 10196.27% up from last year.
- As of Q3 2025, Eli Lilly's EPS (Weighted Average and Diluted) stood at $6.21, which was up 48037.38% from $6.29 recorded in Q2 2025.
- In the past 5 years, Eli Lilly's EPS (Weighted Average and Diluted) registered a high of $6.29 during Q2 2025, and its lowest value of -$0.06 during Q3 2023.
- In the last 5 years, Eli Lilly's EPS (Weighted Average and Diluted) had a median value of $1.95 in 2023 and averaged $2.43.
- As far as peak fluctuations go, Eli Lilly's EPS (Weighted Average and Diluted) crashed by 10372.67% in 2023, and later surged by 188333.33% in 2024.
- Eli Lilly's EPS (Weighted Average and Diluted) (Quarter) stood at $1.89 in 2021, then increased by 13.23% to $2.14 in 2022, then increased by 13.08% to $2.42 in 2023, then skyrocketed by 101.56% to $4.88 in 2024, then rose by 27.31% to $6.21 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $6.21 for Q3 2025, versus $6.29 for Q2 2025 and $3.06 for Q1 2025.